Correction: Later passages of neural progenitor cells from neonatal brain are more permissive for human cytomegalovirus infection [Journal of Virology, 87, 20, (2013) (10968-10979)] doi: 10.1128/JVI.01120-13;Later passages of neural progenitor cells from neonatal brain are more permissive for human cytomegalovirus infection

Journal of Virology

Volumn 87, Issue 20, 2013, Pages 10968-10979

  Pan, Xing ^a   Li, Xiao Jun ^a   Liu, Xi Juan ^a   Yuan, Hui ^b   Li, Jia Fu ^c   Duan, Ying Liang ^a   Ye, Han Qing ^a   Fu, Ya Ru ^a   Qiao, Guan Hua ^a   Wu, Cong Cong ^a   Yang, Bo ^a   Tian, Xiao Hui ^a   Hu, Kang Hong ^a   Miao, Ling Feng ^a   Chen, Xiao Ling ^a   Zheng, Jun ^d   Rayner, Simon ^a   Schwartz, Philip H ^e   Britt, William J ^f   Xu, Jiang ^d   Luo, Min Hua ^a   more..

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b JIANGHAN UNIVERSITY   (China)

^c WUHAN UNIVERSITY   (China)

^d SHIHEZI UNIVERSITY   (China)

^e Children's Hospital of Orange County   (United States)

^f University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RECEPTOR;

ARTICLE; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CELL FATE; CELL ISOLATION; CELL LOSS; CELL STRUCTURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DCX GENE; DOWN REGULATION; GENE; GENETIC MARKER; GESTATIONAL AGE; GFAP GENE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; INFECTION RISK; INFECTION SENSITIVITY; NERVE CELL CULTURE; NEURAL STEM CELL; NEWBORN; NEWBORN PERIOD; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOX2 GENE; VIRUS ENTRY;

HUMAN HERPESVIRUS 5;

EID: 84886922589     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01780-16     Document Type: Erratum

References (70)

1. Ross DS, Dollard SC, Victor M, Sumartojo E, Cannon MJ. 2006. The epidemiology and prevention of congenital cytomegalovirus infection and disease: activities of the Centers for Disease Control and Prevention Workgroup. J. Womens Health (Larchmt.) 15:224-229.
2. Boppana SB, Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, Sanchez PJ, Bernstein DI, Tolan RW, Jr, Novak Z, Chowdhury N, Britt WJ, Fowler KB. 2011. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N. Engl. J. Med. 364:2111-2118.
3. Misono S, Sie KC, Weiss NS, Huang ML, Boeckh M, Norton SJ, Yueh B. 2011. Congenital cytomegalovirus infection in pediatric hearing loss. Arch. Otolaryngol. Head Neck Surg. 137:47-53.
4. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Walton PD, Veren DA, Page F, Alford CA. 1986. Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus, and clinical outcome. JAMA 256:1904-1908.
5. Dar L, Pati SK, Patro AR, Deorari AK, Rai S, Kant S, Broor S, Fowler KB, Britt WJ, Boppana SB. 2008. Congenital cytomegalovirus infection in a highly seropositive semi-urban population in India. Pediatr. Infect. Dis. J. 27:841-843.
6. Wen L, Wu S, Lu S. 1996. The epidemiological study on human cytomegalovirus infection of pregnant women and the maternal-fetal transmission in three Chinese metropolis. Zhonghua Fu Chan Ke Za Zhi 31: 714-717. (In Chinese.)
7. Zhong XY, Ma TY. 1993. A clinical study of cytomegalovirus infections during pregnancy. J. Tongji Med. Univ. 13:60-64.
8. Bale JF, Jr. 1984. Human cytomegalovirus infection and disorders of the nervous system. Arch. Neurol. 41:310-320.
9. Becroft DM. 1981. Prenatal cytomegalovirus infection: epidemiology, pathology, and pathogenesis. Perspect. Pediatr. Pathol. 6:203-241.
10. Conboy TJ, Pass RF, Stagno S, Britt WJ, Alford CA, McFarland CE, Boll TJ. 1986. Intellectual development in school-aged children with asymptomatic congenital cytomegalovirus infection. Pediatrics 77:801-806.
11. Grosse SD, Ross DS, Dollard SC. 2008. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J. Clin. Virol. 41:57-62.
12. Pass RF, Stagno S, Myers GJ, Alford CA. 1980. Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics 66:758-762.
13. Revello MG, Zavattoni M, Furione M, Fabbri E, Gerna G. 2006. Preconceptional primary human cytomegalovirus infection and risk of congenital infection. J. Infect. Dis. 193:783-787.
14. Schachtele SJ, Mutnal MB, Schleiss MR, Lokensgard JR. 2011. Cytomegalovirus- induced sensorineural hearing loss with persistent cochlear inflammation in neonatal mice. J. Neurovirol. 17:201-211.
15. Engman ML, Lewensohn-Fuchs I, Mosskin M, Malm G. Congenital cytomegalovirus infection: the impact of cerebral cortical malformations. Acta Paediatr. 99:1344-1349.
16. Sweeten TL, Posey DJ, McDougle CJ. 2004. Brief report: autistic disorder in three children with cytomegalovirus infection. J. Autism Dev. Disord. 34:583-586.
17. Boppana SB, Fowler KB, Vaid Y, Hedlund G, Stagno S, Britt WJ, Pass RF. 1997. Neuroradiographic findings in the newborn period and longterm outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 99:409-414.
18. Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA. 1992. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr. Infect. Dis. J. 11:93-99.
19. Dahle AJ, Fowler KB, Wright JD, Boppana SB, Britt WJ, Pass RF. 2000. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J. Am. Acad. Audiol. 11:283-290.
20. Karltorp E, Hellstrom S, Lewensohn-Fuchs I, Carlsson-Hansen E, Carlsson PI, Engman ML. Congenital cytomegalovirus infection: a common cause of hearing loss of unknown aetiology. Acta Paediatr. 101:e357-e362.
21. McMullan BJ, Palasanthiran P, Jones CA, Hall BM, Robertson PW, Howard J, Rawlinson WD. 2011. Congenital cytomegalovirus. Time to diagnosis, management, and clinical sequelae in Australia: opportunities for earlier identification. Med. J. Aust. 194:625-629.
22. Barkovich AJ, Lindan CE. 1994. Congenital cytomegalovirus infection of the brain: imaging analysis and embryologic considerations. Am. J. Neuroradiol. 15:703-715.
23. Perlman JM, Argyle C. 1992. Lethal cytomegalovirus infection in preterm infants: clinical, radiological, and neuropathological findings. Ann. Neurol. 31:64-68.
24. Kashiwai A, Kawamura N, Kadota C, Tsutsui Y. 1992. Susceptibility of mouse embryo to murine cytomegalovirus infection in early and midgestation stages. Arch. Virol. 127:37-48.
25. Tebourbi L, Testart J, Cerutti I, Moussu JP, Loeuillet A, Courtot AM. 2002. Failure to infect embryos after virus injection in mouse zygotes. Hum. Reprod. 17:760-764. doi:10.1093/humrep/17.3.760.
26. Tsutsui Y, Naruse I. 1987. Murine cytomegalovirus infection of cultured mouse embryos. Am. J. Pathol. 127:262-270.
27. Tsutsui Y, Kashiwai A, Kawamura N, Kadota C. 1993. Microphthalmia and cerebral atrophy induced in mouse embryos by infection with murine cytomegalovirus in midgestation. Am. J. Pathol. 143:804-813.
28. Melnick M, Mocarski ES, Abichaker G, Huang J, Jaskoll T. 2006. Cytomegalovirus-induced embryopathology: mouse submandibular salivary gland epithelial-mesenchymal ontogeny as a model. BMC Dev. Biol. 6:42. doi:10.1186/1471-213X-6-42.
29. Shimamura M, Murphy-Ullrich JE, Britt WJ. Human cytomegalovirus induces TGF-β1 activation in renal tubular epithelial cells after epithelialto- mesenchymal transition. PLoS Pathog. 6:e1001170. doi:10.1371/journal.ppat.1001170.
30. Tsutsui Y, Kashiwai A, Kawamura N, Kadota C, Nagahama M. 1991. Postnatal porencephaly induced in mouse by murine cytomegalovirus. Acta Neuropathol. 82:435-441.
31. Kawasaki H, Kosugi I, Arai Y, Iwashita T, Tsutsui Y. 2011. Mouse embryonic stem cells inhibit murine cytomegalovirus infection through a multi-step process. PLoS One 6:e17492. doi:10.1371/journal.pone.0017492.
32. Matsukage S, Kosugi I, Kawasaski H, Miura K, Kitani H, Tsutsui Y. 2006. Mouse embryonic stem cells are not susceptible to cytomegalovirus but acquire susceptibility during differentiation. Birth Defects Res. A Clin. Mol. Teratol. 76:115-125.
33. Kosugi I, Kawasaki H, Arai Y, Tsutsui Y. 2002. Innate immune responses to cytomegalovirus infection in the developing mouse brain and their evasion by virus-infected neurons. Am. J. Pathol. 161:919-928.
34. Li RY, Baba S, Kosugi I, Arai Y, Kawasaki H, Shinmura Y, Sakakibara SI, Okano H, Tsutsui Y. 2001. Activation of murine cytomegalovirus immediate-early promoter in cerebral ventricular zone and glial progenitor cells in transgenic mice. Glia 35:41-52.
35. Shinmura Y, Aiba-Masago S, Kosugi I, Li RY, Baba S, Tsutsui Y. 1997. Differential expression of the immediate-early and early antigens in neuronal and glial cells of developing mouse brains infected with murine cytomegalovirus. Am. J. Pathol. 151:1331-1340.
36. Tsutsui Y, Kawasaki H, Kosugi I. 2002. Reactivation of latent cytomegalovirus infection in mouse brain cells detected after transfer to brain slice cultures. J. Virol. 76:7247-7254.
37. Tsutsui Y, Kosugi I, Kawasaki H. 2005. Neuropathogenesis in cytomegalovirus infection: indication of the mechanisms using mouse models. Rev. Med. Virol. 15:327-345.
38. Chang WL, Tarantal AF, Zhou SS, Borowsky AD, Barry PA. 2002. A recombinant rhesus cytomegalovirus expressing enhanced green fluorescent protein retains the wild-type phenotype and pathogenicity in fetal macaques. J. Virol. 76:9493-9504.
39. Kawasaki H, Kosugi I, Arai Y, Tsutsui Y. 2002. The amount of immature glial cells in organotypic brain slices determines the susceptibility to murine cytomegalovirus infection. Lab. Invest. 82:1347-1358.
40. Cheeran MC, Hu S, Ni HT, Sheng W, Palmquist JM, Peterson PK, Lokensgard JR. 2005. Neural precursor cell susceptibility to human cytomegalovirus diverges along glial or neuronal differentiation pathways. J. Neurosci. Res. 82:839-850.
41. Lokensgard JR, Cheeran MC, Gekker G, Hu S, Chao CC, Peterson PK. 1999. Human cytomegalovirus replication and modulation of apoptosis in astrocytes. J. Hum. Virol. 2:91-101.
42. Luo MH, Hannemann H, Kulkarni AS, Schwartz PH, O'Dowd JM, Fortunato EA. 2010. Human cytomegalovirus infection causes premature and abnormal differentiation of human neural progenitor cells. J. Virol. 84:3528-3541.
43. Luo MH, Schwartz PH, Fortunato EA. 2008. Neonatal neural progenitor cells and their neuronal and glial cell derivatives are fully permissive for human cytomegalovirus infection. J. Virol. 82:9994-10007.
44. McCarthy M, Auger D, Whittemore SR. 2000. Human cytomegalovirus causes productive infection and neuronal injury in differentiating fetal human central nervous system neuroepithelial precursor cells. J. Hum. Virol. 3:215-228.
45. Odeberg J, Wolmer N, Falci S, Westgren M, Seiger A, Soderberg-Naucler C. 2006. Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J. Virol. 80: 8929-8939.
46. Odeberg J, Wolmer N, Falci S, Westgren M, Sundtrom E, Seiger A, Soderberg-Naucler C. 2007. Late human cytomegalovirus (HCMV) proteins inhibit differentiation of human neural precursor cells into astrocytes. J. Neurosci. Res. 85:583-593.
47. Lecointe D, Hery C, Janabi N, Dussaix E, Tardieu M. 1999. Differences in kinetics of human cytomegalovirus cell-free viral release after in vitro infection of human microglial cells, astrocytes and monocyte-derived macrophages. J. Neurovirol. 5:308-313.
48. Luo MH, Fortunato EA. 2007. Long-term infection and shedding of human cytomegalovirus in T98G glioblastoma cells. J. Virol. 81:10424-10436.
49. McCarthy M, Resnick L, Taub F, Stewart RV, Dix RD. 1991. Infection of human neural cell aggregate cultures with a clinical isolate of cytomegalovirus. J. Neuropathol. Exp. Neurol. 50:441-450.
50. Sun T, Wang XJ, Xie SS, Zhang DL, Wang XP, Li BQ, Ma W, Xin H. A comparison of proliferative capacity and passaging potential between neural stem and progenitor cells in adherent and neurosphere cultures. Int. J. Dev. Neurosci. 29:723-731.
51. Zietlow R, Precious SV, Kelly CM, Dunnett SB, Rosser AE. Long-term expansion of human foetal neural progenitors leads to reduced graft viability in the neonatal rat brain. Exp. Neurol. 235:563-573.
52. Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ. 2002. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 62:3347-3350.
53. Schwartz PH, Bryant PJ, Fuja TJ, Su H, O'Dowd DK, Klassen H. 2003. Isolation and characterization of neural progenitor cells from postmortem human cortex. J. Neurosci. Res. 74:838-851.
54. Tamashiro JC, Hock LJ, Spector DH. 1982. Construction of a cloned library of the EcoRI fragments from the human cytomegalovirus genome (strain AD169). J. Virol. 42:547-557.
55. Luo MH, Rosenke K, Czornak K, Fortunato EA. 2007. Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (ATM)-and ATM-Rad3-related kinase-mediated DNA damage responses during lytic infection. J. Virol. 81:1934-1950.
56. Kosugi I, Shinmura Y, Kawasaki H, Arai Y, Li RY, Baba S, Tsutsui Y. 2000. Cytomegalovirus infection of the central nervous system stem cells from mouse embryo: a model for developmental brain disorders induced by cytomegalovirus. Lab. Invest. 80:1373-1383.
57. + neural stem cells in the adult hippocampus. Cell Stem Cell 1:515-528.
58. Soroceanu L, Akhavan A, Cobbs CS. 2008. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection. Nature 455:391-395.
59. Wang X, Huang DY, Huong SM, Huang ES. 2005. Integrin alphavbeta3 is a coreceptor for human cytomegalovirus. Nat. Med. 11:515-521.
60. Wang X, Huong SM, Chiu ML, Raab-Traub N, Huang ES. 2003. Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature 424:456-461.
61. Koehler KR, Tropel P, Theile JW, Kondo T, Cummins TR, Viville S, Hashino E. Extended passaging increases the efficiency of neural differentiation from induced pluripotent stem cells. BMC Neurosci. 12:82. doi: 10.1186/1471-2202-12-82.
62. Zaim M, Karaman S, Cetin G, Isik S. Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells. Ann. Hematol. 91:1175-1186.
63. Casavant NC, Luo MH, Rosenke K, Winegardner T, Zurawska A, Fortunato EA. 2006. Potential role for p53 in the permissive life cycle of human cytomegalovirus. J. Virol. 80:8390-8401.
64. Tsutsui Y, Nogami-Satake T. 1990. Differential expression of the major immediate-early gene of human cytomegalovirus. J. Gen. Virol. 71(Pt 1): 115-124.
65. Soderberg-Naucler C, Fish KN, Nelson JA. 1997. Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J. Clin. Invest. 100: 3154-3163.
66. Tsutsui Y. 2009. Effects of cytomegalovirus infection on embryogenesis and brain development. Congenit. Anom. (Kyoto) 49:47-55.
67. Poland SD, Bambrick LL, Dekaban GA, Rice GP. 1994. The extent of human cytomegalovirus replication in primary neurons is dependent on host cell differentiation. J. Infect. Dis. 170:1267-1271.
68. Poland SD, Costello P, Dekaban GA, Rice GP. 1990. Cytomegalovirus in the brain: in vitro infection of human brain-derived cells. J. Infect. Dis. 162:1252-1262.
69. Boppana SB, Miller J, Britt WJ. 1996. Transplacentally acquired antiviral antibodies and outcome in congenital human cytomegalovirus infection. Viral Immunol. 9:211-218.
70. Schleiss MR. 2008. Cytomegalovirus vaccine development. Curr. Top. Microbiol. Immunol. 325:361-382.